Thomas Malley
CIK 1403322 · last filed 2026-06-04
Thomas Malley is a corporate insider who has filed 70 SEC Form 4 insider transactions across 7 companies since 2008. The most recent filing, for KURA, was dated Jun 4, 2026. Across all open-market trades the lifetime net is −$1.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$7.03M
7
70
-$1.87M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KURA | Director | 149,557 | $9.05 | $1.35M | $975.0K | 14 | 2026-06-04 |
| KNSA | Director | 87,312 | $51.89 | $4.53M | -$5.86M | 11 | 2026-06-02 |
| BeOne Medicines Ltd. (BGNE) Delisted | Director | 46,696 | $184.71 | $8.63M | $960.0K | 8 | 2023-06-20 |
| Tempest Therapeutics, Inc. (OVAS) Delisted | Director | 204,981 | — | — | $1.89M | 16 | 2017-07-05 |
| SYNAGEVA BIOPHARMA CORP (GEVA) Delisted | Director | 0 | — | — | $0 | 6 | 2015-06-23 |
| PBYI | Director | 156,551 | $7.33 | $1.15M | $160.0K | 4 | 2014-12-16 |
| Cougar Biotechnology, Inc. (CGRB) Delisted | Director | 0 | — | — | $0 | 2 | 2009-07-07 |
Recent Filings
70 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-04 | KURA | Grant (A) | — | $0 | EDGAR |
| 2026-06-02 | KNSA | Mixed | +2,799 | $0 | EDGAR |
| 2026-03-20 | KURA | Exer (M) | +10,000 | $31.2K | EDGAR |
| 2025-08-14 | KNSA | Mixed | — | -$4.04M | EDGAR |
| 2025-06-06 | KURA | Grant (A) | — | $0 | EDGAR |
| 2025-06-05 | KNSA | Mixed | +3,173 | $0 | EDGAR |
| 2024-06-07 | KNSA | Mixed | +4,373 | $0 | EDGAR |
| 2024-06-07 | KURA | Grant (A) | — | $0 | EDGAR |
| 2023-07-03 | KNSA | Exer (M) | +5,000 | $0 | EDGAR |
| 2023-06-21 | KURA | Buy (P) | +50,000 | $575.0K | EDGAR |